Péter Ferdinandy
About
Péter Ferdinandy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine.
According to data from OpenAlex, Péter Ferdinandy has authored 237 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 85 papers in Cardiology and Cardiovascular Medicine and 77 papers in Pathology and Forensic Medicine. Recurrent topics in Péter Ferdinandy's work include Cardiac Ischemia and Reperfusion (76 papers), Nitric Oxide and Endothelin Effects (31 papers) and Cardiac Arrest and Resuscitation (25 papers). Péter Ferdinandy is often cited by papers focused on Cardiac Ischemia and Reperfusion (76 papers), Nitric Oxide and Endothelin Effects (31 papers) and Cardiac Arrest and Resuscitation (25 papers). Péter Ferdinandy collaborates with scholars based in Hungary, Germany and United States. Péter Ferdinandy's co-authors include Rainer Schulz, Gary F. Baxter, Zoltán Giricz, Zoltán V. Varga, Derek J. Hausenloy, Gerd Heusch, Tamás Csont, Pál Pacher, Lucas Liaudet and David García‐Dorado and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Bioinformatics.
In The Last Decade
Péter Ferdinandy
234 papers receiving 11.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Péter Ferdinandy Hungary | 53 | 5.0k | 3.5k | 3.1k | 1.6k | 1.5k | 237 | 11.4k | ||
| Rakesh C. Kukreja United States | 62 | 4.8k 1.0× | 3.4k 1.0× | 3.2k 1.0× | 2.3k 1.4× | 1.0k 0.7× | 210 | 11.0k | ||
| Nilanjana Maulik United States | 64 | 5.1k 1.0× | 3.7k 1.1× | 1.7k 0.5× | 2.0k 1.2× | 867 0.6× | 228 | 11.0k | ||
| Christopher Baines United States | 47 | 6.7k 1.3× | 3.6k 1.0× | 1.7k 0.5× | 1.3k 0.8× | 728 0.5× | 81 | 11.3k | ||
| Michael Marber United Kingdom | 58 | 4.1k 0.8× | 2.6k 0.7× | 3.8k 1.2× | 1.2k 0.7× | 502 0.3× | 248 | 10.5k | ||
| Charles Steenbergen United States | 72 | 7.4k 1.5× | 5.7k 1.6× | 4.9k 1.6× | 2.4k 1.4× | 1.1k 0.7× | 206 | 16.5k | ||
| Zhengyuan Xia China | 50 | 3.2k 0.6× | 2.0k 0.6× | 1.5k 0.5× | 1.2k 0.7× | 844 0.6× | 275 | 8.9k | ||
| Tetsuji Miura Japan | 58 | 4.1k 0.8× | 3.5k 1.0× | 4.1k 1.3× | 1.7k 1.0× | 459 0.3× | 393 | 12.7k | ||
| Edward J. Lesnefsky United States | 55 | 6.3k 1.3× | 3.0k 0.9× | 1.9k 0.6× | 1.9k 1.1× | 506 0.3× | 198 | 10.8k | ||
| Fabio Di Lisa Italy | 59 | 7.7k 1.5× | 2.9k 0.8× | 1.9k 0.6× | 2.0k 1.2× | 404 0.3× | 135 | 12.3k | ||
| Masafumi Kitakaze Japan | 74 | 6.1k 1.2× | 3.8k 1.1× | 8.2k 2.6× | 2.8k 1.7× | 706 0.5× | 474 | 19.4k |
Countries citing papers authored by Péter Ferdinandy
Since
Specialization
Citations
This map shows the geographic impact of Péter Ferdinandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Ferdinandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Ferdinandy more than expected).
Fields of papers citing papers by Péter Ferdinandy
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Péter Ferdinandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Ferdinandy. The network helps show where Péter Ferdinandy may publish in the future.
Co-authorship network of co-authors of Péter Ferdinandy
This figure shows the co-authorship network connecting the top 25 collaborators of Péter Ferdinandy. A scholar is included among the top collaborators of Péter Ferdinandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Ferdinandy. Péter Ferdinandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Marton, S., András Makkos, Kimberly Glass, et al.. (2024). Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence. British Journal of Pharmacology. 182(2). 340–379.
2.
Michel, Lars, Péter Ferdinandy, & Tienush Rassaf. (2024). Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction. Current Heart Failure Reports. 21(3). 214–223.
3.
Izzo, Angelo A., Andreas Papapetropoulos, S P H Alexander, et al.. (2024). Natural product pharmacology: the British Journal of Pharmacology perspective. British Journal of Pharmacology. 181(19). 3547–3555.
4.
Pipis, Judit, András Makkos, Bence Ágg, et al.. (2024). Identification of New, Translatable ProtectomiRs against Myocardial Ischemia/Reperfusion Injury and Oxidative Stress: The Role of MMP/Biglycan Signaling Pathways. Antioxidants. 13(6). 674–674.
5.
Papapetropoulos, Andreas, Stavros Topouzis, S P H Alexander, et al.. (2024). Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. British Journal of Pharmacology. 181(11). 1553–1575.
6.
Gigante, Bruna, Juan Tamargo, Stefan Agewall, et al.. (2024). Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(7). 614–645.
7.
Onódi, Zsófia, Petra Lujza Szabó, Péter Pokreisz, et al.. (2023). Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 24(10). 8497–8497.
8.
Schaefer, Anne‐Kristin, Attila Kiss, André Oszwald, et al.. (2022). Single Donor Infusion of S-Nitroso-Human-Serum-Albumin Attenuates Cardiac Isograft Fibrosis and Preserves Myocardial Micro-RNA-126-3p in a Murine Heterotopic Heart Transplant Model. Transplant International. 35. 10057–10057.
9.
Ferdinandy, Péter, Ioanna Andreadou, Gary F. Baxter, et al.. (2022). Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological Reviews. 75(1). 159–216.
10.
Hegyesi, Hargita, Éva Pállinger, Gábor B. Brenner, et al.. (2022). Circulating cardiomyocyte-derived extracellular vesicles reflect cardiac injury during systemic inflammatory response syndrome in mice. Cellular and Molecular Life Sciences. 79(2). 84–84.
11.
Ferenczyová, Kristína, Monika Benkovičová, Bernadett Kiss, et al.. (2021). Helium Conditioning Increases Cardiac Fibroblast Migration Which Effect Is Not Propagated via Soluble Factors or Extracellular Vesicles. International Journal of Molecular Sciences. 22(19). 10504–10504.
12.
Pesce, Maurizio, Piergiuseppe Agostoni, Hans Erik Bøtker, et al.. (2021). COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research. 117(10). 2148–2160.
13.
Badimón, Lina, Emma Robinson, Amela Jusić, et al.. (2021). Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovascular Research. 117(8). 1823–1840.
14.
Blanco, Isabel, Gábor Kovács, Zsuzsanna Helyes, et al.. (2020). Pulmonary hypertension in chronic obstructive pulmonary disease. British Journal of Pharmacology. 178(1). 132–151.
15.
Brenner, Gábor B., András Makkos, Csilla Terézia Nagy, et al.. (2020). Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. Cells. 9(3). 551–551.
16.
Andreadou, Ioanna, Rainer Schulz, Lina Badimón, et al.. (2019). Hyperlipidaemia and cardioprotection: Animal models for translational studies. British Journal of Pharmacology. 177(23). 5287–5311.
17.
Brenner, Gábor B., András Makkos, Mihály Balogh, et al.. (2019). Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat. Cells. 8(3). 251–251.
18.
Madonna, Rosalinda, Carmela Rita Balistreri, Salvatore De Rosa, et al.. (2019). Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease. Journal of Clinical Medicine. 8(1). 98–98.
19.
Madonna, Rosalinda, Stefania Angelucci, Fabrizio Di Giuseppe, et al.. (2019). Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin. Journal of Molecular and Cellular Cardiology. 131. 171–186.
20.
Čarnická, Slávka, Adrián Szobi, Zoltán Giricz, et al.. (2016). Data on necrotic and apoptotic cell death in acute myocardial ischemia/reperfusion injury: the effects of CaMKII and angiotensin AT1 receptor inhibition. Data in Brief. 7. 730–734.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rakesh C. Kukreja Breakdown of academic impact, for papers by Nilanjana Maulik Breakdown of academic impact, for papers by Christopher Baines Breakdown of academic impact, for papers by Michael Marber Breakdown of academic impact, for papers by Charles Steenbergen Breakdown of academic impact, for papers by Zhengyuan Xia Breakdown of academic impact, for papers by Tetsuji Miura Breakdown of academic impact, for papers by Edward J. Lesnefsky Breakdown of academic impact, for papers by Fabio Di Lisa Breakdown of academic impact, for papers by Masafumi Kitakaze